Autor segons l'article: Rey-Renones, Cristina; Martinez-Torres, Sara; Martin-Lujan, Francisco M.; Pericas, Carles; Redondo, Ana; Vilaplana-Carnerero, Carles; Dominguez, Angela; Grau, Maria;
Departament: Medicina i Cirurgia Ciències Mèdiques Bàsiques
Autor/s de la URV: Martín Lujan, Francisco Manuel
Paraules clau: Type-2 diabetes mellitus Therapy Risk-factors People Outcomes New-york-city Inhibitors Glucose Epidemiology Covid-19 Bidirectional link Antidiabetic treatment Adults
Resum: Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values in most high- and middle-income countries. T2DM could be a risk factor of developing complications in other diseases. Indeed, some studies suggest a bidirectional interaction between T2DM and COVID-19. A growing body of evidence shows that COVID-19 prognosis in individuals with T2DM is worse compared with those without. Moreover, various studies have reported the emergence of newly diagnosed patients with T2DM after SARS-CoV-2 infection. The most common treatments for T2DM may influence SARS-CoV-2 and their implication in infection is briefly discussed in this review. A better understanding of the link between TD2M and COVID-19 could proactively identify risk factors and, as a result, develop strategies to improve the prognosis for these patients.
Àrees temàtiques: Pharmacology & pharmacy Medicine, research & experimental Medicine (miscellaneous) General biochemistry,genetics and molecular biology Ciencias sociales Biochemistry, genetics and molecular biology (miscellaneous) Biochemistry, genetics and molecular biology (all) Biochemistry & molecular biology
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: paco.martin@urv.cat
Identificador de l'autor: 0000-0003-0359-3588
Data d'alta del registre: 2024-09-07
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://www.mdpi.com/2227-9059/10/9/2089
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Biomedicines. 10 (9):
Referència de l'ítem segons les normes APA: Rey-Renones, Cristina; Martinez-Torres, Sara; Martin-Lujan, Francisco M.; Pericas, Carles; Redondo, Ana; Vilaplana-Carnerero, Carles; Dominguez, Angel (2022). Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Biomedicines, 10(9), -. DOI: 10.3390/biomedicines10092089
DOI de l'article: 10.3390/biomedicines10092089
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2022
Tipus de publicació: Journal Publications
Repositori URV